Market Dashboard
- You are here:
- Home
- Markets
- Market Dashboard
- Glaxosmithkline Pharmaceuticals Ltd.
NSE Symbol: | BSE Code: | ISIN: | Sector:
- Add to Portfolio
- Add to Watchlist
- Add to Alert
- Add to Message
Add to Portfolio
NSE
1548.25
| Change | Change % |
| 36.10 | 2.39% |
Updated:29 Sep, 2023, 15:56 PM IST |
|
BSE
1544.50
| Change | Change % |
| 36.10 | 2.39% |
Updated:29 Sep, 2023, 16:01 PM IST |
|
Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)
Day's Range
1514.301567.00
52 Wk Range
1225.20 1812.00
Compare Price performance of vs. Peer Companies
From sector
Compare with Peers on Key Fundamentals and Financials
- SUNPHARMA
2.38% - DIVISLAB
2.75% - CIPLA
1.96% - DRREDDY
2.97% - CADILAHC
2.09% - AUROPHARMA
4.60% - LUPIN
3.37% - ABBOTINDIA
3.44% - ALKEM
2.41% - BIOCON
2.12% - TORNTPHARM
3.36% - GLAXO
2.39% - GLENMARK
9.88% - PEL
3.35% - PFIZER
0.46% - SANOFI
2.09% - NATCOPHARM
0.30% - AJANTPHARM
4.13% - APLLTD
2.72% - ERIS
3.18% - JBCHEPHARM
5.79% - IPCALAB
1.17% - ASTRAZEN
0.98% - GRANULES
3.85% - MERCK
-0.04% - CAPLINLABS
0.77% - FDC
-1.29% - NEULANDLAB
-2.64% - STAR
1.27% - MARKSANS
0.92%
's Latest Research Report
| Brokerage/Analyst | Report Date | Call | Price@Call | Target | Current Status | Report |
|---|---|---|---|---|---|---|
| Nomura - |
28-06-2017 | Sell | 2440.00 | 2056.00 | Target Hit | Details |
Glaxosmithkline Phar's Key Fundamentals
| Parameter | Values |
|---|---|
| Market Cap (in ₹ Cr.) | 26,228.28 |
| Earning Per Share (EPS TTM) (₹) | 30.34 |
| Price To Earnings (P/E) Ratio | 51.03 |
| Book Value Per Share (₹) | 126.47 |
| Price To Books (P/B) Ratio | 12.24 |
| EBIT Margin (%) | 21.23 |
| PAT Margin (%) | 13.60 |
| ROCE (%) | 31.45 |
| PAT Growth (%) | 20.85 |
| Total Debt to Equity (D/E) Ratio | 0.00 |
More from Key Fundamentals »
Glaxosmithkline Phar's Financial Summary
| Parameter | MAR'19 (₹ Cr.) |
MAR'18 (₹ Cr.) |
YoY %Change |
|---|---|---|---|
| Balance Sheet: | |||
| Share Capital | 169.41 | 84.70 | 100.00% |
| Total Non-Current Liabilities | 2,835.06 | 2,572.79 | 10.19% |
| Total Current Liabilities | 2,800.62 | 2,945.16 | -4.91% |
| Total Liabilities | 7,778.10 | 7,597.90 | 2.37% |
| Total Non-Current Assets | 4,437.17 | 4,085.73 | 8.60% |
| Currents Investments | 0.00 | 0.00 | 0.00% |
| Cash and Bank | 1,155.33 | 1,279.69 | -9.72% |
| Total Current Assets Excluding Current Investments | 3,340.93 | 3,512.17 | -4.88% |
| Total Assets | 7,778.10 | 7,597.90 | 2.37% |
| Profit and Loss: | |||
| Gross Sales | 3,128.53 | 2,895.88 | 8.03% |
| Net Sales | 3,128.53 | 2,871.69 | 8.94% |
| PBIDT (Excl OI) | 606.48 | 508.44 | 19.28% |
| PAT | 425.36 | 351.99 | 20.85% |
More from Financial Summary »
Glaxosmithkline Phar's Shareholding Pattern
| Description | Percent of Share (%) |
|---|---|
| Promoters | 50.67 |
| Individuals | 14.28 |
| Institutions | 14.46 |
| FII | 18.24 |
| Govt. | 0.00 |
| Others | 2.35 |
More from Holding Pattern »
Glaxosmithkline Phar held by Mutual Fund Schemes
More from Mutual Fund Holding »
..